Collegium Pharmaceutical (COLL)
Commercializes ADHD and pain-management medicines across a U.S. prescription portfolio.
$22.82
vs last close−0.22 (−0.95%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 121.74% | 39.63M shares | |
|---|---|---|---|
| 283 holders · as of Jun 30, 2026 | |||
| Insiders | 12.25% | 3.99M shares | |
| 17 holders · as of Jun 10, 2026 | |||
| Strategic holders | 11.04% | 3.59M shares | |
| 2 holders · as of Aug 24, 2026 | |||
| Adds to | 145.03% | ||
32.56M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
These groups come from separate filings that can overlap, so they add to 145.03%; nothing is left for Other.
13F, as of Jun 30, 2026
283 holders · 39.63M shares · 46 new positions · 166 increased · 85 reduced · 33 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 5.44M | 16.71% | +307.2K | Aug 7, 2026 |
| Jupiter Topco LLC | 2.15M | 6.60% | +2.15Mnew | Aug 14, 2026 |
| Invesco Ltd. | 1.88M | 5.78% | +290.6K | Aug 14, 2026 |
| Fuller & Thaler Asset Management, Inc. | 1.63M | 5.02% | +133.2K | Aug 12, 2026 |
| Principal Financial Group Inc | 1.63M | 5.01% | +337.3K | Aug 4, 2026 |
| State Street Corp | 1.53M | 4.70% | +104.3K | Aug 7, 2026 |
| Massachusetts Financial Services Co /MA/ | 1.41M | 4.32% | +39.6K | Aug 3, 2026 |
| Vanguard Capital Management LLC | 1.38M | 4.24% | +47.3K | Aug 13, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 15.60% | 5.00M | 13G | Apr 28, 2025 |
| Janus Henderson Group PLC | 5.80% | 1.83M | 13G | May 15, 2026 |
| Principal Global Investors, LLC | 5.42% | 1.75M | Nov 13, 2024 | |
| Integrated Core Strategies (US) LLC | 5.40% | 1.77M | 13G | Aug 24, 2026 |
| Fuller & Thaler Asset Management, Inc. | 5.03% | 1.63M | 13G | Aug 14, 2026 |
| Vanguard Capital Management | 5.01% | 1.63M | 13G | Jul 31, 2026 |
| Principal Global Investors | 5.00% | 1.63M | 13G | Aug 5, 2026 |
| Invesco Ltd. | 5.00% | 1.59M | 13G | May 8, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| May 18, 2026 | John Gordon Freunddirector | Sale | 20 | $34.05 | 83,952 |
| May 15, 2026 | John Gordon Freunddirector | Sale | 4,127 | $34.54 | 83,972 |
| May 13, 2026 | Nancy Lurkerdirector | Sale | 4,500 | $35.97 | 18,017 |
| May 11, 2026 | Garen G. Bohlindirector | Sale | 8,700 | $37.18 | 62,259 |
| Mar 18, 2026 | David Dieterofficer: EVP & General Counsel | Sale | 13,976 | $34.92 | 77,071 |
| Mar 9, 2026 | David Dieterofficer: EVP & General Counsel | Sale | 6,224 | $36.65 | 91,047 |
| Mar 3, 2026 | Scott Dreyerofficer: EVP & Chief Commercial Officer | Sale · 2 lots | 49,976 | $40.41 | 71,770 |
| Dec 8, 2025 | Scott Dreyerofficer: EVP & Chief Commercial Officer | Sale · 2 lots | 17,600 | $48.17 | 103,613 |
| Dec 5, 2025 | Rita J. Balice-Gordondirector | Sale | 3,650 | $47.03 | 52,629 |
| Nov 12, 2025 | John A. Fallondirector | Sale | 34,853 | $47.21 | 64,634 |
House and Senate disclosures
Not reported.